Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LivaNova (LIVN) Research & Development (2016 - 2025)

LivaNova's Research & Development history spans 12 years, with the latest figure at $52.1 million for Q4 2025.

  • For Q4 2025, Research & Development rose 20.35% year-over-year to $52.1 million; the TTM value through Dec 2025 reached $185.8 million, up 1.78%, while the annual FY2025 figure was $185.8 million, 1.78% up from the prior year.
  • Research & Development for Q4 2025 was $52.1 million at LivaNova, up from $48.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $52.6 million in Q2 2021 and bottomed at $34.2 million in Q2 2022.
  • The 5-year median for Research & Development is $45.3 million (2022), against an average of $45.1 million.
  • The largest annual shift saw Research & Development skyrocketed 108.96% in 2021 before it plummeted 34.87% in 2022.
  • A 5-year view of Research & Development shows it stood at $44.1 million in 2021, then grew by 1.89% to $44.9 million in 2022, then rose by 2.74% to $46.2 million in 2023, then fell by 6.19% to $43.3 million in 2024, then rose by 20.35% to $52.1 million in 2025.
  • Per Business Quant, the three most recent readings for LIVN's Research & Development are $52.1 million (Q4 2025), $48.6 million (Q3 2025), and $47.2 million (Q2 2025).